Liver toxicity and pioglitazone: Data are missing

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7471.918 (Published 14 October 2004) Cite this as: BMJ 2004;329:918
  1. Peshraw Amin (peshakan@hotmail.com), consultant endocrinologist
  1. Derby Royal Infirmary Hospital, Derby DE1 2QY

    EDITOR—The interesting drug point by Farley-Hills et al, on fatal liver failure associated with pioglitazone, is missing data.1 I hope that it will remind doctors to monitor liver function and not cause a scare similar to that which …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription